According to the international ranking of the research portal Research.com, a total of 18 cluster members are among the world's best in medicine. Cluster spokesman Prof. Stefan Schreiber is ranked 118th in the international comparison.
18 researchers of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) have been honored for their research achievements by the science portal Research.com. Cluster spokesman Prof. Stefan Schreiber received the "Medicine Leader Award." Schreiber is Director of the Institute for Clinical Molecular Biology at Schleswig-Holstein University Hospital (UKSH), Kiel Campus and Christian-Albrechts-Universität zu Kiel (CAU), Director of the Clinic for Internal Medicine I at UKSH and Professor at the Medical Faculty of CAU.
The portal has created a ranking of leading scientists in medicine. A total of 892 "Best Medicine Scientists" are listed in Germany and more than 17,000 worldwide. In Germany, Prof. Schreiber leads this ranking in first place. In a worldwide comparison, he is in 118th place.
According to Research.com, data from around 68,900 scientists worldwide were evaluated for the ranking. The USA dominates the ranking with the most leading medical experts, with Germany taking third place after the UK. The selection criteria for the ranking of top scientists are based on the proportion of publications within the respective field as well as the awards and achievements of the researchers, the portal says. Research.com had already listed the world's best researchers last year; a breakdown by field was added this year.
„Best Medicine Scientists“ from the PMI Cluster
Prof. Dr. Lars Bertram, Prof. Dr. Ingolf Cascorbi, Prof. Dr. Jeanette Erdmann, Prof. Dr. Andre Franke, Prof. Dr. Axel Hauschild, Prof. Dr. Olav Jansen, Prof. Dr. Wolfram Klapper, Prof. Dr. Christine Klein, Prof. Dr. Inke König, Prof. Dr. Michael Krawczak, Prof. Dr. Christoph Lange, Prof. Dr. Ulrich Mrowietz, Prof. Dr. Klaus Rabe, Prof. Dr. Christoph Röcken, Prof. Dr. Stefan Rose-John, Prof. Dr. Philip Rosenstiel, Prof. Dr. Stefan Schreiber, Prof. Dr. Detlef Zillikens
About the Cluster of Excellence PMI
The Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) is being funded from 2019 to 2025 through the German Excellence Strategy (ExStra). It succeeds the "Inflammation at Interfaces” Cluster, which was already funded in two periods of the Excellence Initiative (2007-2018). Around 300 members from eight institutions at four locations are involved: Kiel (Kiel University, University Medical Center Schleswig-Holstein (UKSH), Muthesius University of Fine Arts and Design, Kiel Institute for the World Economy (IfW), Leibniz Institute for Science and Mathematics Education (IPN)), Lübeck (University of Lübeck, University Medical Center Schleswig-Holstein (UKSH)), Plön (Max Planck Institute for Evolutionary Biology) and Borstel (Research Center Borstel - Leibniz Lung Center).
The goal is to translate interdisciplinary research findings on chronic inflammatory diseases of barrier organs to healthcare more intensively, as well as to fulfil previously unsatisfied needs of the patients. Three points are important in the context of successful treatment, and are therefore at the heart of PMI research: the early detection of chronic inflammatory diseases, the prediction of disease progression and complications, and the prediction of individual responses to treatment.